USE OF PHOSPHORIC TRIAMIDES IN TOILETS

Information

  • Patent Application
  • 20100215611
  • Publication Number
    20100215611
  • Date Filed
    August 08, 2007
    17 years ago
  • Date Published
    August 26, 2010
    14 years ago
Abstract
The present invention describes the use of phosphoric triamides in toilets.
Description

Phosphoric triamides are described in U.S. Pat. No. 4,530,714. The use of these compounds is likewise described therein—upon use in crop growth media, these contribute in the field to the nitrogen content in the soil being retained.


U.S. Pat. No. 5,770,771 discloses a multistage process for the preparation of N-hydrocarbyl-thiophosphoric triamides, e.g. of N-(n-butyl)thiophosphoric triamide.


WO 2006/010389 A1 deals in turn with the use of phosphoric triamides. Here, a number of uses is mentioned: the avoidance of nitrogen losses in the case of the use of nitrogen-based fertilizers, the avoidance of the ammonia nuisance in animal stalls, the use of urea as feed additive in animal nutrition, and also medical applications.

    • The avoidance of nitrogen losses in the case of the use of nitrogen-based fertilizers is accordingly achieved by the enzymatic urease-catalyzed urea hydrolysis being suppressed—if appropriate in combination with a parallel limitation of the nitrification. This is said to avoid high ammonia concentrations in the soil, which can adversely affect germination and the emergence of seedlings.
    • By inhibiting the enzymatic urease-catalyzed urea hydrolysis, the aim is likewise to avoid the sometimes considerable ammonia nuisance in stalls, which can adversely affect the development and the growth of the animals.
    • And also, according to WO 2006/010389 A1, in this way, the partial substitution of the high-value protein-rich plant nutrition of animals through so-called “non-protein nitrogen compounds” is possible. Here, urea can be used if it is possible to control the urease-catalyzed urea hydrolysis occurring in the rumen of the animals in such a way that the released ammonia rates can be processed immediately by microorganisms that are present to give microbial protein and thus can trigger no toxic reactions.
    • In the medical sector, the urease inhibitors are proposed for the prophylaxis or treatment of disorders or diseases which are directly or indirectly induced or encouraged by urease activity. Examples are catheter encrustations, ulcerous stomach and intestinal diseases, urolithiasis, pyelonephritis, nephrolithiasis, ammonia encephalopathy, hepatic encephalopathy, hepatic coma, urinary tract infections and gastrointestinal infections.


DE 102 52 382 A1 likewise deals with the avoidance of nitrogen losses in the case of the use of nitrogen-based fertilizers, the avoidance of the ammonia nuisance in animal stalls and the use of urea as feed additive in animal nutrition. In this connection, it describes phosphoric ester diamides as extremely effective urease inhibitors. It likewise describes N-(n-butyl)thiophosphoric triamide as a derivative of phosphoric triamide, although it is described as being relatively susceptible to hydrolysis. DE 102 52 382 A1 teaches the use of tetraaminophosphonium salts as particularly readily suitable compounds for the specified applications.


U.S. Pat. No. 6,869,923 describes a perfume composition which can be used in the sanitary sector in cleaners. However, this composition has the disadvantage that a user who only wishes to avoid the odor or urine during and after cleaning does not have this option, but can conceal the odor only by means of another, generally perceived as pleasant.


U.S. Pat. No. 6,376,457 also describes a perfume composition for use in cleaners in the sanitary sector. Here too, the user does not have the option of avoiding the unpleasant odor of urine—he can conceal it merely by means of a more intensive—again generally perceived as pleasant—odor.


U.S. Pat. No. 6,625,821, which deals essentially with a dispersion device for cleaners and fragrances in toilets, likewise only describes the use of fragrances for solving the problem of urine odor in the sanitary sector.







This gives rise to the object of reducing and avoiding as far as possible the odor of urine which comes from toilets.


Surprisingly, this object is achieved through the use according to claim 1, the compositions according to any one of claims 2 to 25, the dosing devices according to claims 26 and 27 and the kit of parts according to claim 28.


The use of N-alkylthiophosphoric triamide for improving the odor of toilets achieves the object of the invention. The N-alkylthiophosphoric triamide(s) can be used alone or together with other substances.


A composition for use in toilets comprising at least one N-alkylthiophosphoric triamide thus is likewise provided by the present invention.


In this case, preference is given to a composition in which the one or more N-alkylthiophosphoric triamide(s) is/are selected from the group consisting of: methylthiophosphoric triamide, ethylthiophosphoric triamide, N-propylthiophosphoric triamide (linear or branched), N-butylthiophosphoric triamide (linear or branched), N-pentylthiophosphoric triamide (linear or branched), N-hexylthiophosphoric triamide (linear or branched), N-cyclohexylthiophosphoric triamide, N-heptylthiophosphoric triamide (linear or branched), N-cycloheptylthiophosphoric triamide, N-octylthio-phosphoric triamide (linear or branched), N-cyclooctylthiophosphoric triamide.


In this connection particular preference is given to a composition which comprises at least two N-alkylthiophosphoric triamides. Here, the most preferred embodiment is one in which the composition comprises N-propylthiophosphoric triamide and N-butylthio-phosphoric triamide.


Furthermore, preference is given to a composition in which the (total) amount of N-alkylthiophosphoric triamide(s) is 0.001 to 100 mass %, preferably 0.01 to 90 mass %, particularly preferably 0.1 to 50 mass % and most preferably 0.5 to 10 mass %.


Here, the statement “(total) amount” is to be understood as meaning that in cases where only one n-alkylthiophosphoric triamide or only one further constituent according to the invention is present in the composition, the amount of this substance is to be taken into consideration, whereas in cases where two or more n-alkylthiophosphoric triamides or two or more constituents according to the invention are present, the sum of each of these is to be taken into consideration. Thus, if the compound comprises, for example, x mass % of anionic surfactant and y mass % of cationic surfactant, then, in the consideration, x+y mass % of surfactant is to be used as a basis.


A further preferred embodiment of the present invention is a composition which further comprises at least one surfactant selected from the group consisting of anionic surfactants, cationic surfactants, betaine surfactants and nonionic surfactants.


Surfactants generally consist of a hydrophobic moiety and of a hydrophilic moiety. Here, the hydrophobic moiety generally has a chain length of from 4 to 20 carbon atoms, preferably 6 to 19 carbon atoms and particularly preferably 8 to 18 carbon atoms. The functional unit of the hydrophobic group is generally an OH group, where the alcohol may be branched or unbranched. The hydrophilic moiety generally essentially consists of alkoxylated units (e.g. ethylene oxide (EO), propylene oxide (PO) and/or butylene oxide (BO), where usually 2 to 30, preferably 5 to 20, of these alkoxylated units are strung together, and/or charged units, such as sulfate, sulfonate, phosphate, carboxylic acids, ammonium and ammonium oxide.


Examples of anionic surfactants are: carboxylates, sulfonates, sulfo fatty acid methyl esters, sulfates, phosphates. Examples of cationic surfactants are: quaternary ammonium compounds. Examples of betaine surfactants are: alkylbetaines. Examples of nonionic compounds are: alcohol alkoxylates.


Here, a “carboxylate” is understood as meaning a compound which has at least one carboxylate group in the molecule. Examples of carboxylates which can be used according to the invention are

    • soaps—e.g. stearates, oleates, cocoates of the alkali metals or of ammonium,
    • ether carboxylates—e.g. Akypo® RO 20, Akypo® RO 50, Akypo® RO 90.


A “sulfonate” is understood as meaning a compound which has at least one sulfonate group in the molecule. Examples of sulfonates which can be used according to the invention are

    • alkylbenzenesulfonates—e.g. Lutensit® A-LBS, Lutensit® A-LBN, Lutensit® A-LBA, Marlon@ AS3, Maranil® DBS,
    • alkylsulfonates—e.g. Alscoap OS-14P, BIO-TERGE® AS-40, BIO-TERGE® AS-40 CG, BIO-TERGE® AS-90 Beads, Calimulse® AOS-20, Calimulse® AOS-40, Calsoft® AOS-40, Colonial® AOS-40, Elfan® OS 46, Ifrapon® AOS 38, Ifrapon® AOS 38 P, Jeenate® AOS-40, Nikkol® OS-14, Norfox® ALPHA XL, POLYSTEP® A-18, Rhodacal® A-246L, Rhodacal® LSS-40/A,
    • sulfonated oils, such as, for example, Turkish red oil,
    • olefinsulfonates,
    • aromatic sulfonates—e.g. Nekal® BX, Dowfax® 2A1.


Here, a “sulfo fatty acid methyl ester” is understood as meaning a compound which has the following unit of the general formula (I):







in which R has 10 to 20 carbon atoms; preferably, R has 12 to 18 and particularly preferably 14 to 16 carbon atoms.


Here, a “sulfate” is understood as meaning a compound which has at least one SO4 group in the molecule. Examples of sulfates which can be used according to the invention are

    • fatty alcohol sulfates, such as, for example, coconut fatty alcohol sulfate (CAS 97375-27-4)—e.g. EMAL® 10G, Dispersogen® SI, Elfan® 280, Mackol® 100N,
    • other alcohol sulfates—e.g. Emal® 71, Lanette® E,
    • coconut fatty alcohol ether sulfate—e.g. Emal® 20C, Latemul® E150, Sulfochem® ES-7, Texapon® ASV-70 Spec., Agnique SLES-229-F, Octosol 828, POLYSTEP® B-23, Unipol® 125-E, 130-E, Unipol® ES-40,
    • other alcohol ether sulfates—e.g. Avanel® S-150, Avanel® S 150 CG, Avanel® S 150 CG N, Witcolate® D51-51, Witcolate® D51-53.


A “phosphate” is presently understood as meaning a compound which has at least one PO4 group in the molecule. Examples of phosphates which can be used according to the invention are

    • alkyl ether phosphates—e.g. Maphos® 37P, Maphos® 54P, Maphos® 37T, Maphos® 210T and Maphos® 210P,
    • phosphates such as Lutensit A-EP,
    • alkyl phosphates.


A “quaternary ammonium compound” is understood as meaning a compound which has at least one R4N+group in the molecule. Examples of quaternary ammonium compounds which can be used according to the invention are

    • halides, methosulfates, sulfates and carbonates of coconut, tallow fatty or cetyl/oleyltrimethylammonium.


Furthermore, a “betaine surfactant” is understood as meaning a compound which, under application conditions, i.e. under standard pressure and at room temperature (20° C.) or under the conditions as have been chosen in the examples for the simulation, carries at least one positive and one negative charge. An “alkylbetaine” here is a betaine surfactant which has at least one alkyl unit in the molecule. Examples of betaine surfactants which can be used according to the invention are cocamidopropylbetaine—e.g. MAFO® CAB, Amonyl® 380 BA, AMPHOSOL® CA, AMPHOSOL® CG, AMPHOSOL® CR, AMPHOSOL® HCG; AMPHOSOL® HCG-50, Chembetaine® C, Chembetaine® CGF, Chembetaine® CL, Dehyton® PK, Dehyton® PK 45, Emery® 6744, Empigen® BS/F, Empigen® BS/FA, Empigen® BS/P, Genagen® CAB, Lonzaine® C, Lonzaine® CO, Mirataine® BET-C-30, Mirataine® CB, Monateric® CAB, Naxaine® C, Naxaine® CO, Norfox® CAPB, Norfox® Coco Betaine, Ralufon® 414, TEGO®-Betaine CKD, TEGO® Betaine E KE 1, TEGO®-Betaine F, TEGO®-Betaine F 50 and amine oxides, such as, for example, alkyldimethylamine oxides, i.e. compounds of the general formula (II)







in which R1, R2 and R3, independently of one another, are an aliphatic, cyclic or tertiary alkyl or amidoalkyl radical, such as, for example Mazox® LDA, Genaminox®, Aromox® 14 DW 970.


Nonionic surfactants are interface-active substances with a head group which is uncharged, does not carry an ion charge in the neutral pH range, is polar, hydrophilic and water-solubilizing (in contrast to anionic and cationic surfactants), and which adsorbs to interfaces and aggregates above the critical micelle concentration (cmc) to give neutral micelles. Depending on the type of hydrophilic head group, a distinction can be made between (oligo)oxyalkylene groups, in particular (oligo)oxyethylene groups (polyethylene glycol groups), which include the fatty alcohol polyglycol ethers (fatty alcohol alkoxylates), alkylphenol polyglycol ethers, and fatty acid ethoxylates, alkoxylated triglycerides and mixed ethers (polyethylene glycol ethers alkylated on both sides); and carbohydrate groups, which include, for example, the alkyl polyglucosides and fatty acid N-methylglucamides.


Alcohol alkoxylates are based on a hydrophobic moiety with a chain length of from 4 to 20 carbon atoms, preferably 6 to 19 carbon atoms and particularly preferably 8 to 18 carbon atoms, where the alcohol may be branched or unbranched, and a hydrophilic moiety, which may be alkoxylated units, e.g. ethylene oxide (EO), propylene oxide (PO) and/or butylene oxide (BuO), with 2 to 30 repeat units. Examples are, inter alia, Lutensol® XP, Lutensol® XL, Lutensol® ON, Lutensol® AT, Lutensol® A, Lutensol® AO, Lutensol® TO.


Alcohol phenol alkoxylates are compounds of the general formula (III),







which are prepared by the addition of alkylene oxide, preferably of ethylene oxide, onto alkylphenols. Preferably, R4=H here. It is furthermore preferred if R5=H,—it is thus EO; likewise it is preferred if R5=CH3, it is thus PO, or if R5=CH2CH3 and it is BuO. Moreover, particular preference is given to a compound in which octyl-[(R1=R3=H, R2=1,1,3,3-tetramethylbutyl(diisobutylene)], nonyl-[(R1=R3=H, R2=1,3,5-tri-methylhexyl(tripropylene)], dodecyl-, dinonyl- or tributylphenol polyglycol ethers (e.g. ED, PO, BuO) R—C6H4—O-(EO/PO/BuO)n where R=C8 to C12 and n=5 to 10, are present. Nonexhaustive examples of such compounds are: Norfox® OP-102, Surfonic® OP-120, T-Det® O-12.


Fatty acid ethoxylates are fatty acid esters after-treated with varying amounts of ethylene oxide (EO).


Triglycerides are esters of glycerol (glycerides) in which all three hydroxy groups are esterified with fatty acids. These can be modified with alkylene oxide.


Fatty acid alkanolamides are compounds of the general formula (IV)







which has at least one amide group with an alkyl radical R and one or two alkoxy radical(s), where R comprises 11 to 17 carbon atoms and 1≦m+n≦5.


Alkyl polyglycosides are mixtures of alkyl monoglucoside (alkyl-α-D- and -β-D-glucopyranoside, and small fractions of -glucofuranoside), alkyl diglucosides (-isomaltosides, -maltosides and others) and alkyl oligoglucosides (-maltotriosides, -tetraosides and others). Alkyl polyglycosides are accessible, inter alia, by acid-catalyzed reaction (Fischer reaction) from glucose (or starch) or from n-butyl glucosides with fatty alcohols. Alkyl polyglycosides correspond to the general formula (V)







in which


m=0 to 3 and


n=4 to 20.


One example is Lutensol® GD70.


In the group of nonionic N-alkylated, preferably N-methylated, fatty acid amides of the general formula (VI)







R1 is usually an n-C12-alkyl radical, R2 is an alkyl radical having 1 to 8 carbon atoms.


R2 is preferably methyl.


The advantage of adding these surfactants is that they lower the interfacial tension and thus ensure good wetting.


In this connection, there are preferred quantitative ranges, and preference is given to a composition in which the at least one surfactant is present in an amount of from 0.01 to 99 mass %, preferably from 0.5 to 50 mass %, particularly preferably from 1 to 25 mass % and most preferably from 2 to 15 mass %.


Since the N-alkylthiophosphoric alkylamides have a reduced storage stability in the presence of strong acids and bases, preference is given to a composition which has a pH in the range from 5 to 9 and preferably from 6 to 8, such as 6.5, 7 or 7.5. However, the composition can also be used with strong acids or bases. Here, preference is given to using the dosing devices described in more detail below.


A further preferred embodiment of the present invention is a composition which additionally comprises at least one of the following substances: disinfectant, fragrance, dye.


A composition as described which further comprises at least one disinfectant is particularly preferred. Here, the at least one disinfectant is present in the composition in a (total) amount of from 0.1 to 20 mass %, preferably from 1 to 10 mass %.


Disinfectants may be: oxidizing agents, halogens such as chlorine and iodine and substances releasing these, alcohols such as ethanol, 1-propanol and 2-propanol, aldehydes, phenols, ethylene oxide, detergents, chlorhexidine and mecetronium metilsulfate.


The advantage of using disinfectants is that pathogens in the toilet are hardly able to spread. Pathogens may be: bacteria, spores, fungi or viruses.


A composition which further comprises at least one fragrance is particularly preferred.


Fragrances may be individual compounds or mixtures of alcohols, aldehydes, terpenes and/or esters. Examples of fragrances are: lemongrass oil, cochin, dihydromyrcenol, lilial, phenylethyl alcohol, tetrahydrolinalool, hexenol cis-3, lavandin grosso, citral, allyl caproate, citronitrile, benzyl acetate, hexylcinnamaldehyde, citronellol, isoamyl salicylate, isobornyl acetate, terpinyl acetate, linalyl acetate, terpinyl acetate, dihydromyrcenol, agrunitrile, eucalyptus oil, herbaflorat and orange oil. The advantage of using fragrances is that the toilet gives a freshly cleaned impression and conceals unpleasant odors.


The composition comprises therefore preferably at least one fragrance in a (total) amount of from 0.1 to 20 mass %, particularly preferably from 1 to 10 mass %.


Furthermore a composition is preferred which further comprises at least one dye.


Dyes may be, inter alia: Acid Blue 9, Acid Yellow 3, Acid Yellow 23, Acid Yellow 73, Pigment Yellow 101, Acid Green 1, Acid Green 25. The advantage of using dyes in toilets is that they give the impression that something has been done to keep them clean.


Preference is therefore given to a composition in which the at least one dye is present in a (total) amount of from 0.1 to 20 mass % of from 1 to 10 mass %.


Further constituents of the composition according to the invention may for example be: polymers, complexing agents, acids, bases, biocides, hydrotopes and thickeners.


Polymers may be: adducts consisting of ethylene oxide (E0) and/or propylene oxide (PO) and/or butylene oxide (BuO). The arrangement of the monomers here may be alternating, random or blockwise. Preference is given to compounds in which the distribution is essentially blockwise. Examples of such compounds are Pluronics®.


Complexing agents are compounds which are able to bind cations. This can be utilized in order to reduce the hardness of water and in order to precipitate out troublesome heavy metal ions. Examples of complexing agents are NTA, EDTA, MGDA and GLDA. The advantage of using these compounds is that by reducing the water hardness, it is possible to avoid the occurrence of lime deposits in the toilet.


Acids are compounds which are advantageously used to dissolve or prevent lime deposits. Examples of acids are formic acid, acetic acid, citric acid, hydrochloric acid, sulfuric acid and sulfonic acid.


Bases are compounds which can advantageously be used for establishing the favorable pH range for complexing agents. Examples of bases which can be used according to the invention are: NaOH, KOH and aminoethanol.


Biocides are compounds which kill bacteria. One example of a biocide is glutaraldehyde. The advantage of using biocides is that they counteract the spread of pathogens.


Hydrotropes are compounds which improve the solubility of the surfactant/surfactants in the composition. One example of a hydrotrope is: cumene sulfonate.


Thickeners are compounds which increase the viscosity of the composition. Examples of thickeners are: e.g. polyacrylates or hydrophobically modified polyacrylates. The advantage of using thickeners is that liquids with a higher viscosity have less tendency to splash and thus the area soiled upon use in and around the toilet can be reduced.


A dosing devite for the composition according to the invention is further provided by the present invention. A dosing device within the context of this invention is a vessel which comprises the composition according to the invention and releases it through at least one opening. Here, the removal can take place as a result of the force of gravity, e.g. by pouring out through an opening, by pumping, e.g. by generating a superatmospheric pressure in the vessel, or else by applying a subatmospheric pressure from outside. A dosing device in which the composition is packaged in portions which suffices for one (single dose) or more toilets is likewise provided by the present invention. The composition is then preferably enclosed in a water-soluble container which releases the composition upon contact with water. This container can simply be thrown into the toilet and releases the composition after a short time. The container here can consist of any water-soluble material which is able to enclose the composition and release it as required, e.g. a polyvinyl alcohol. Particular preference is given here to a dosing device in which at least two of the constituents of the composition according to the invention are only mixed with one another at the point of delivery. This type of dosing device is particularly advantageous when, besides the at least one N-alkylthiophosphoric triamide, one or more surfactants are used which are especially acidic or basic. If further constituents are acids or bases, it is particularly advantageous to separate these and also to separate these from the N-alkylthiophosphoric triamide(s) during storage and only to combine the constituents upon use.


The use of compositions comprising N-alkylthiophosphoric triamide is particularly advantageous in toilets which have flush device providing no or only a limited amount of water, and also in toilets whose wastewater is collected over a certain period of time. These are in particular mobile toilets, which are used, for example, on building sites, at large events, on camping sites, in caravans/mobile homes, etc.


A kit of parts consisting of at least two substances that are to be used simultaneously or successively which together correspond to the composition according to the invention is further provided by the present invention. Thus, for example, the one or more N-alkylthiophosphoric triamide(s) may be present in one container, and the one or more surfactants may be present in a second container. Separation into strongly acidic and/or strongly basic constituents on the one hand and the one or more N-alkylthiophosphoric triamide(s) on the other hand can thus also be realized and lies within the scope of the present invention. Besides allowing the essentially simultaneous use of the various constituents, such a kit of parts also allows a staggered use of the constituents. Thus, for example, firstly the odor avoidance with the composition comprising N-alkylthiophosphoric triamide(s) can take place and then the cleaning of the toilet with a surfactant-containing composition can be prepared/carried out.

Claims
  • 1-28. (canceled)
  • 29. A composition for improving the odor in toilets comprising N-alkylthiophosphoric triamide.
  • 30. A composition for use in toilets, comprising at least one N-alkylthiophosphoric triamide and at least one of the substances selected from the group consisting of: acid, base, complexing agent, biocide, hydrotrope, thickener, disinfectant, and fragrance.
  • 31. The composition according to claim 30, in which the one or more N-alkylthiophosphoric triamide(s) is/are selected from the group consisting of: methylthiophosphoric triamide, ethylthiophosphoric triamide, N-propylthio-phosphoric triamide (linear or branched), N-butylthiophosphoric triamide (linear or branched), N-pentylthiophosphoric triamide (linear or branched), N-hexylthio-phosphoric triamide (linear or branched), N-cyclohexylthiophosphoric triamide, N-heptylthiophosphoric triamide (linear or branched), N-cycloheptyl-thiophosphoric triamide, N-octylthiophosphoric triamide (linear or branched), and N-cyclooctylthiophosphoric triamide.
  • 32. The composition according to claim 30, which comprises at least two N-alkylthiophosphoric triamides.
  • 33. The composition according to claim 30, in which the total amount of N-alkylthiophosphoric triamide(s) is 0.001 to 100 mass %.
  • 34. The composition according to claim 33, in which the total amount of N-alkylthio-phosphoric triamide(s) is 0.01 to 90 mass %.
  • 35. The composition according to claim 34, in which the total amount of N-alkylthiophosphoric triamide(s) is 0.1 to 50 mass %.
  • 36. The composition according to claim 35, in which the total amount of N-alkylthiophosphoric triamide(s) is 0.5 to 10 mass %.
  • 37. The composition according to claim 30 which further comprises at least one surfactant selected from the group consisting of anionic surfactants, cationic surfactants, betaine surfactants and nonionic surfactants.
  • 38. The composition according to claim 30, in which the at least one surfactant is present in a total amount of from 0.01 to 99 mass %.
  • 39. The composition according to claim 38, in which the at least one surfactant is present in a total amount of from 0.5 to 50 mass %.
  • 40. The composition according to claim 39, in which the at least one surfactant is present in a total amount of from 1 to 25 mass %.
  • 41. The composition according to claim 40, in which the at least one surfactant is present in a total amount of from 2 to 15 mass %.
  • 42. The composition according to claim 30, in which the at least one disinfectant is present in a total amount of from 0.1 to 20 mass %.
  • 43. The composition according to claim 42, in which the at least one disinfectant is present in a total amount of from 1 to 10 mass %.
  • 44. The composition according to claim 30, in which the at least one fragrance is present in a total amount of from 0.1 to 20 mass %.
  • 45. The composition according to claim 44, in which the at least one fragrance is present in a total amount of from 1 to 10 mass %.
  • 46. The composition according to claim 30, which further comprises at least one dye.
  • 47. The composition according to claim 46, in which the at least one dye is present in a total amount of from 0.1 to 20 mass %.
  • 48. The composition according to claim 47, in which the at least one dye is present in a total amount of from 1 to 10 mass %.
  • 49. The composition according to claim 29, which has a pH in the range from 5 to 9.
  • 50. The composition according to claim 49, which has a pH of from 6 to 8.
  • 51. A dosing device comprising a composition according to claim 30.
  • 52. A dosing device in which at least two of the constituents of the composition according to claim 30 are only mixed with one another at the point of delivery.
  • 53. A kit of parts consisting of at least two substances to be used simultaneously or successively which together correspond to the composition according to claim 30.
Priority Claims (1)
Number Date Country Kind
06119498.1 Aug 2006 EP regional
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP2007/058210 8/8/2007 WO 00 2/12/2009